DJIA 17,856.78 -278.94 -1.54%
NASDAQ 4,927.37 -55.44 -1.11%
S&P 500 2,071.26 -29.78 -1.42%
market minute promo

4.32 0.09 (2.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $4.32 2.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.23
Previous Close $4.23
Daily Range $4.23 - $4.37
52-Week Range $3.26 - $7.24
Market Cap $1.0B
P/E Ratio -15.11
Dividend (Yield) $0.00 (0.0%)
Volume 4,609,923
Average Daily Volume 5,213,617
Current FY EPS -$0.47




Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary Rss Feed

Why Arena Pharmaceuticals, Inc. Burst Today

Arena Pharmaceuticals shares slumped after reporting lackluster earnings and competitors positive news.

Arena Pharmaceuticals (ARNA) Marked As A Dead Cat Bounce Stock

Orexigen Soars: Good News Is Heart Data, Bad News Is Data May Be Compromised

Arena's Post Earnings Sell-Off Offers A Good Opportunity To Buy

Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog

Why Orexigen Therapeutics, Inc. Stock Exploded Higher

Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Arena Pharmaceuticals (ARNA) Stock: Weak On High Volume Today

Morning Market Losers

Benzinga's Top #PreMarket Losers

See More ARNA News...

ARNA's Top Competitors

ARNA $4.32 (2.13%)
Current stock: ARNA
AMGN $154.88 (-2.96%)
Current stock: AMGN
GILD $101.81 (-1.55%)
Current stock: GILD
BIIB $417.63 (-1.87%)
Current stock: BIIB